Summary:
High Point Clinical Trials Center is conducting a research study using an investigational drug that is being developed for type 2 diabetes mellitus (T2DM).This is the first study to evaluate the safety effects and how well the body is able to tolerate multiple doses of the drug compared to placebo when administered with no other oral antidiabetic drug (OAD) treatments.
Qualified Participants Must:
• Have Type 2 Diabetes
•
Be between 18 and 70 years of age
Qualified Participants May Receive:
Compensation may be available for your time and travel.